363 related articles for article (PubMed ID: 18828858)
1. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.
Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing
Clin Microbiol Infect; 2008 Oct; 14(10):982-4. PubMed ID: 18828858
[No Abstract] [Full Text] [Related]
2. EUCAST Technical Note on voriconazole.
Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing
Clin Microbiol Infect; 2008 Oct; 14(10):985-7. PubMed ID: 18828859
[No Abstract] [Full Text] [Related]
3. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).
Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope W;
Clin Microbiol Infect; 2012 Jul; 18(7):E246-7. PubMed ID: 22563750
[TBL] [Abstract][Full Text] [Related]
4. [An update on antifungal susceptibility testing].
Tapia P CV
Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
[TBL] [Abstract][Full Text] [Related]
5. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.
Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)
Clin Microbiol Infect; 2008 Apr; 14(4):398-405. PubMed ID: 18190574
[No Abstract] [Full Text] [Related]
6. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility testing methods of antifungal agents.
Ernst EJ
Methods Mol Med; 2005; 118():3-12. PubMed ID: 15888930
[TBL] [Abstract][Full Text] [Related]
8. [Determining the susceptibility of microfungi to antifungals and interpreting the results].
Mallátová N
Klin Mikrobiol Infekc Lek; 2007 Aug; 13(4):150-5. PubMed ID: 17929220
[TBL] [Abstract][Full Text] [Related]
9. EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.
Arendrup MC; Meletiadis J; Mouton JW; Guinea J; Cuenca-Estrella M; Lagrou K; Howard SJ;
Clin Microbiol Infect; 2016 Jun; 22(6):571.e1-4. PubMed ID: 26851656
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility testing.
Fothergill AW; Rinaldi MG; Sutton DA
Infect Dis Clin North Am; 2006 Sep; 20(3):699-709. PubMed ID: 16984876
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of resistance to antifungals.
Rodriguez-Tudela JL; Alcazar-Fuoli L; Cuesta I; Alastruey-Izquierdo A; Monzon A; Mellado E; Cuenca-Estrella M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S111-3. PubMed ID: 19013333
[TBL] [Abstract][Full Text] [Related]
12. [Has a decade of standardizing antifungal sensitivity tests accomplished anything?].
Rodríguez Tudela JL; Cuenca Estrella M
Enferm Infecc Microbiol Clin; 2002 May; 20(5):191-3. PubMed ID: 12006254
[No Abstract] [Full Text] [Related]
13. Colorimetric broth microdilution method for the antifungal screening of plant extracts against yeasts.
Liu M; Seidel V; Katerere DR; Gray AI
Methods; 2007 Aug; 42(4):325-9. PubMed ID: 17560320
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies.
Rivero-Menendez O; Cuenca-Estrella M; Alastruey-Izquierdo A
J Antimicrob Chemother; 2019 May; 74(5):1295-1299. PubMed ID: 30753499
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
Jainkittivong A; Butsarakamruha T; Langlais RP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):394-8. PubMed ID: 19716507
[TBL] [Abstract][Full Text] [Related]
16. Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi.
Rodriguez-Tudela JL; Chryssanthou E; Petrikkou E; Mosquera J; Denning DW; Cuenca-Estrella M
J Clin Microbiol; 2003 Nov; 41(11):5236-7. PubMed ID: 14605171
[TBL] [Abstract][Full Text] [Related]
17. Postantifungal effect methods.
Vitale RG
Methods Mol Med; 2005; 118():153-8. PubMed ID: 15888941
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the results of a broth microdilution antifungal susceptibility testing in vitro.
Buchta V; Otcenásek M
Zentralbl Bakteriol; 1996 Mar; 283(3):375-90. PubMed ID: 8861876
[TBL] [Abstract][Full Text] [Related]
19. New technique for testing antifungal agents.
Oncology (Williston Park); 1990 Dec; 4(12):32. PubMed ID: 2149036
[No Abstract] [Full Text] [Related]
20. Evaluation of the inhibitory effect of amphotericin B on the apical growth of F. solani using the BioCell-Tracer system.
Teixeira AB; Moretti ML; Machado HC; Nishimura K; Taguchi H; Schreiber AZ
Mycoses; 2007 May; 50(3):183-8. PubMed ID: 17472613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
